Elsevier

Human Pathology

Volume 13, Issue 3, March 1982, Pages 199-209
Human Pathology

Fibrous histiocytoma of the orbit: A clinicopathologic study of 150 cases**,***

https://doi.org/10.1016/S0046-8177(82)80178-0Get rights and content

This is a clinicopathologic study of 150 cases of fibrous histiocytoma of the orbit. The tumors occurred in adults (median age, 43 years). The upper and nasal portions of the orbit were the most common sites of involvement. The most common signs and symptoms were proptosis (60 per cent), mass (46 per cent), and decreased vision (25 per cent). Based on the histopathologic features, the tumors were classified in three groups: benign (94 cases), locally aggressive (39 cases), and malignant (17 cases). The biologic behavior correlated well with the duration of symptoms, the size and margins of the mass, and the histologic classification. The rate of recurrence was 31 per cent for the benign tumors, 57 per cent for the locally aggressive tumors, and 64 per cent for the malignant tumors. Follow-up data were obtained for 123 patients, with a mean duration of seven years. The ten-year survival of patients with benign, locally aggressive, and malignant fibrous histiocytoma was 100 per cent, 92 per cent, and 23 per cent, respectively. Nine patients died as a result of the tumor, six from local invasion of adjacent structures and three from metastatic disease. Fibrous histiocytoma is the most common primary mesenchymal orbital tumor of adults. The origin of the neoplasm is probably a primitive mesenchymal cell. Complete surgical excision appears to be the treatment of choice.

References (23)

  • BiednerB et al.

    Orbital fibrous histiocytoma in an infant

    Am J Ophthalmol

    (1978)
  • JakobiecFA et al.

    Fibrous histiocytomas of the orbit

    Am J Ophthalmol

    (1974)
  • ChurgAM et al.

    Myofibroblasts and related cells in malignant fibrous and fibrohistiocytic tumors

    Hum Pathol

    (1977)
  • KaufmanSL et al.

    Histiocytic tumors (fibrous xanthoma and histiocytoma) in children

    Cancer

    (1961)
  • Ozello L et al.

    Cultural characteristics of malignant histiocytomas and fibrous xanthomas

    Cancer

    (1963)
  • KempsonRL et al.

    Fibroxanthosarcoma of the soft tissues. A type of malignant fibrous histiocytoma

    Cancer

    (1972)
  • FuYS et al.

    Malignant soft tissue tumors of probably histiocytic origin (malignant fibrous histiocytomas): general considerations and electron microscopic and tissue culture studies

    Cancer

    (1975)
  • WeissSW et al.

    Malignant fibrous histiocytoma. An analysis of 200 cases

    Cancer

    (1978)
  • StoutAP et al.

    Tumors of the soft tissues

  • EnzingerFM et al.

    Histologic typing of soft tissue tumors

  • O'BrienJE et al.

    Malignant fibrous xanthoma

    Cancer

    (1964)
  • Cited by (110)

    • Benign fibrous histiocytoma of the medial rectus muscle

      2022, Journal of AAPOS
      Citation Excerpt :

      Epibulbar presentation is relatively rare.3 It accounts for about 1% of all orbital tumors.1,2 These tumors are soft-tissue tumors with spindle-shaped, plump histiocyte-like cells, with focal storiform architecture of primitive mesenchymal origin.1,4

    • Mesenchymal orbital tumors

      2010, Neurochirurgie
    • Changing patterns in orbital pathology

      2018, Saudi Journal of Ophthalmology
    • Introduction to Orbital Diseases

      2022, Albert and Jakobiec's Principles and Practice of Ophthalmology: Fourth Edition
    • Mesenchymal, Fibroosseous, and Cartilaginous Orbital Tumors

      2022, Albert and Jakobiec's Principles and Practice of Ophthalmology: Fourth Edition
    View all citing articles on Scopus
    **

    This investigation was supported in part by research grant EY-01386 from the National Eye Institute.

    ***

    The opinoions and assertions contained herein are the private views of the authors and are not to be construed as official or as reflecting the views of the Department of the Army or the Department of Defense.

    *

    Received from the Cullan Eye Institute, Baylor College of Medicine, Houston, Text,

    and the Registry of Ophthalmic Pathology, Armed Forces Institute of Pathology, Washington, DC.

    View full text